SCHEMBL5373513

SCHEMBL5373513

COc1ccc(C([C]=O)[N+](=O)[O-])cc1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
CYP2C19 P33261 2/20 0.47
VCP P55072 1/20 0.43
ACHE P22303 4/20 0.41
CYP19A1 P11511 1/20 0.41
PTGS2 P35354 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
PPARG P37231 1/20 0.41
PPARD Q03181 1/20 0.41
PPARA Q07869 1/20 0.41
MAPT P10636 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TSHR P16473 2/20 0.40
POLB P06746 1/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25771 0.78 ALDH1A1 (0.45) ALDH1A1CYP2C19VCPACHECYP19A1
SCHEMBL10759367 0.78 CYP2C19 (0.50) ALDH1A1CYP2C19VCPACHECYP19A1
Bromide SCHEMBL7268772 0.77 CYP2C19 (0.49) ALDH1A1CYP2C19VCPACHECYP19A1
Water SCHEMBL7268737 0.77 ALDH1A1 (0.49) ALDH1A1CYP2C19VCPACHECYP19A1
SCHEMBL3042994 0.77 CYP2C19 (0.52) ALDH1A1CYP2C19VCPACHECYP19A1
SCHEMBL8911523 0.75 ATM (0.48) ALDH1A1CYP2C19ACHECA1CA2
SCHEMBL910620 0.74 ACHE (0.50) ALDH1A1CYP2C19ACHECA1CA2
SCHEMBL20592075 0.73 ALDH1A1 (0.49) ALDH1A1CYP2C19VCPACHECYP19A1
Bicarbonate SCHEMBL7262670 0.73 CYP2C19 (0.52) ALDH1A1CYP2C19ACHECA1CA2
SCHEMBL4099979 0.73 ACHE (0.54) ALDH1A1CYP2C19VCPACHECA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2751291-A2 METHODS FOR PREPARING HIGH THROUGHPUT PEPTIDOMIMETICS, ORALLY BIOAVAILABLE DRUGS AND COMPOSITIONS CONTAINING SAME University of Southern California (US) 2014-07-09 EP disclosed
WO-2013033636-A2 METHODS FOR PREPARING HIGH THROUGHPUT PEPTIDOMIMETICS, ORALLY BIOAVAILABLE DRUGS AND COMPOSITIONS CONTAINING SAME UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2013-03-07 WO disclosed
US-7301041-B2 Bi-functional metallocenes, preparation process and use in the labeling or biological molecules BIO MERIEUX (FR) 2007-11-27 US disclosed
US-20060252051-A1 Method for producing diverse libraries of encoded polymers JOHN HOPKINS UNIVERSITY, THE 2006-11-09 US disclosed
US-20050038234-A1 Such as 1-[3-O-dimethoxytritylpropyl]-1'-[3'-O-(2-cyanoethyl-N,N-diisopropylphosphoramidityl)propyl]ferrocene for solid phase synthesis of oligonucleotides/peptides BIO MERIEUX 2005-02-17 US disclosed
WO-2004087730-A2 METHOD FOR PRODUCING DIVERSE LIBRARIES OF ENCODED POLYMERS THE JOHNS HOPKINS UNIVERSITY (US) 2004-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038234-A1 Such as 1-[3-O-dimethoxytritylpropyl]-1'-[3'-O-(2-cyanoethyl-N,N-diisopropylphosphoramidityl)propyl]ferrocene for solid phase synthesis of oligonucleotides/peptides FTH1, DOHH, NSUN2 ALDH1A1 4008/4885CYP2C19 4285/4885VCP 4007/4885
US-20060252051-A1 Method for producing diverse libraries of encoded polymers NSUN3, TRMT1, TARBP1 ALDH1A1 4039/4885CYP2C19 4159/4885VCP 1133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.